- Home
- Publications
- Publication Search
- Publication Details
Title
Ticagrelor
Authors
Keywords
-
Journal
DRUGS
Volume 71, Issue 7, Pages 909-933
Publisher
Springer Nature
Online
2011-05-14
DOI
10.2165/11206850-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-dose ticagrelor does not prolong the QT interval in healthy subjects
- (2011) K. Butler et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Adenosine release: A potential explanation for the benefits of ticagrelor in the PLATelet Inhibition and Clinical Outcomes trial?
- (2010) Victor L. Serebruany AMERICAN HEART JOURNAL
- A New Era for Antiplatelet Therapy in Patients With Acute Coronary Syndrome
- (2010) Chadi Dib et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Ticagrelor Effectively and Reversibly Blocks Murine Platelet P2Y 12 -Mediated Thrombosis and Demonstrates a Requirement for Sustained P2Y 12 Inhibition to Prevent Subsequent Neointima
- (2010) Shankar B. Patil et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers
- (2010) Kathleen Butler et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function
- (2010) Stefan James et al. CIRCULATION
- Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies
- (2010) Paul A. Gurbel et al. CIRCULATION
- Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile?
- (2010) Luke Tapp et al. CIRCULATION
- Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention
- (2010) Philippe Gabriel Steg et al. CIRCULATION
- First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel
- (2010) Udaya S. Tantry et al. Circulation-Cardiovascular Genetics
- Changes in Inflammatory Biomarkers in Patients Treated With Ticagrelor or Clopidogrel
- (2010) Steen Husted et al. CLINICAL CARDIOLOGY
- In Vitro Evaluation of Potential Drug-Drug Interactions with Ticagrelor: Cytochrome P450 Reaction Phenotyping, Inhibition, Induction, and Differential Kinetics
- (2010) D. Zhou et al. DRUG METABOLISM AND DISPOSITION
- Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects
- (2010) R. Teng et al. DRUG METABOLISM AND DISPOSITION
- Coronary atherosclerosis: extending to the microcirculation?
- (2010) J. A. Panza EUROPEAN HEART JOURNAL
- Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2010) Stefan James et al. EUROPEAN HEART JOURNAL
- Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
- (2010) et al. EUROPEAN HEART JOURNAL
- Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12 receptor antagonist, in healthy subjects
- (2010) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Ticagrelor for the treatment of arterial thrombosis
- (2010) Paul A Gurbel et al. EXPERT OPINION ON PHARMACOTHERAPY
- Clopidogrel and the Reduced-Function CYP2C19 Genetic Variant
- (2010) Valentin Fuster et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
- (2010) Claes Held et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antithrombotic therapy in acute coronary syndromes: guidelines translated for the clinician
- (2010) S. Michael Gharacholou et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
- (2010) Christopher P Cannon et al. LANCET
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- Clopidogrel with or without Omeprazole in Coronary Artery Disease
- (2010) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mode of action of P2Y12 antagonists as inhibitors of platelet function
- (2010) D. Iyú et al. THROMBOSIS AND HAEMOSTASIS
- Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model
- (2010) Xiaorong Zhou et al. THROMBOSIS AND HAEMOSTASIS
- Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2009) Stefan James et al. AMERICAN HEART JOURNAL
- Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases
- (2009) Jolanta M Siller-Matula et al. BRITISH JOURNAL OF PHARMACOLOGY
- Ticagrelor: The First Reversibly Binding Oral P2Y12Receptor Antagonist
- (2009) Steen Husted et al. Cardiovascular Therapeutics
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Prasugrel
- (2009) Sean T. Duggan et al. DRUGS
- Prevalence and risk factors related to infections of cardiac resynchronization therapy devices
- (2009) C. Romeyer-Bouchard et al. EUROPEAN HEART JOURNAL
- The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature
- (2009) Carl Högberg et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Ticagrelor binds to human P2Y12independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation
- (2009) J. J. J. VAN GIEZEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ticagrelor — Is There Need for a New Player in the Antiplatelet-Therapy Field?
- (2009) Albert Schömig NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations inP2RY12, P2RY1,andITGB3
- (2009) Robert F. Storey et al. PLATELETS
- The TRITON versus PLATO trials: Differences beyond platelet inhibition
- (2009) Victor Serebruany THROMBOSIS AND HAEMOSTASIS
- Comparison of ticagrelor and thienopyridine P2Y12 binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis
- (2009) J.J.J. van Giezen et al. THROMBOSIS RESEARCH
- Safety Issues of Maternal Drug Therapy During Breastfeeding
- (2008) CM Berlin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation
- (2008) et al. EUROPEAN HEART JOURNAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started